[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@biotech_brian](/creator/twitter/biotech_brian)
"BeiGene thrived when founders joined forces with professional CEOs and BD leaders Xiaodong Wang & John Oyler but when should a biotech involve professional ##ChinaBiotech #Leadership #ScalingUp"  
[X Link](https://x.com/biotech_brian/status/1971627082750087643) [@biotech_brian](/creator/x/biotech_brian) 2025-09-26T17:25Z XXX followers, XX engagements


"China innovation in biotech does happen overnight $SMMT Tx partner Akeso CEO Michelle Xia noted during #STATSummit in Boston"  
[X Link](https://x.com/biotech_brian/status/1978564350651646061) [@biotech_brian](/creator/x/biotech_brian) 2025-10-15T20:51Z XXX followers, XXX engagements


"The latest ivonescimab data from #ESMO25 reinforces what Akeso CEO Xia noted during #STATSummit STATSummit last week that more scrutiny over data from China is anticipated but the quality has improved since Beijings ICH membership in 2017"  
[X Link](https://x.com/biotech_brian/status/1980310615005753630) [@biotech_brian](/creator/x/biotech_brian) 2025-10-20T16:30Z XXX followers, XX engagements


"Interesting Junshis JS207 faces off Opdivo while Akeso picks tislelizumab. What is the rational GM Dr. Zuo pointed Opdivo being first I/O success gives JS207 good references as the potential I/O XXX leader"  
[X Link](https://x.com/biotech_brian/status/1980313435419341102) [@biotech_brian](/creator/x/biotech_brian) 2025-10-20T16:41Z XXX followers, XX engagements